
    
      This is an open label, single center, prospective, first in man pilot study in which the
      investigational device, NitiLoop micro-catheter, will be tested in up to 15 patients with
      symptomatic peripheral arterial occlusive disease scheduled to undergo CTO in an anterograde
      approach.
    
  